These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 27156164)

  • 1. Editorial overview: Nanobiotechnology at a crossroads: moving beyond proof of concept.
    Nash MA; Shoseyov O
    Curr Opin Biotechnol; 2016 Jun; 39():vii-ix. PubMed ID: 27156164
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial overview: Nanobiotechnology: A time-stamped cross-sectional analysis.
    Medintz IL; Tirrell M
    Curr Opin Biotechnol; 2015 Aug; 34():vii-ix. PubMed ID: 26189581
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial overview: Nanobiotechnology: Baby steps and giant strides towards molecular mastery.
    Howarth M; Jaramillo A
    Curr Opin Biotechnol; 2018 Jun; 51():iv-vi. PubMed ID: 29891031
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial overview: Nanobiotechnology.
    Dordick JS; Lee KH
    Curr Opin Biotechnol; 2014 Aug; 28():iv-v. PubMed ID: 24996481
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial Overview: Nanobiotechnology.
    Suess B; Hermann T
    Curr Opin Biotechnol; 2020 Jun; 63():iii-v. PubMed ID: 32563495
    [No Abstract]   [Full Text] [Related]  

  • 6. Hydrological tracers using nanobiotechnology: proof of concept.
    Sharma AN; Luo D; Walter MT
    Environ Sci Technol; 2012 Aug; 46(16):8928-36. PubMed ID: 22831647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STI prevention services online: moving beyond the proof of concept.
    Rietmeijer CA; McFarlane M
    Sex Transm Dis; 2008 Aug; 35(8):770-1. PubMed ID: 18607307
    [No Abstract]   [Full Text] [Related]  

  • 8. Right ventricular resynchronization: moving beyond proof of concept.
    Dubin AM; Rosenthal DN
    Heart Rhythm; 2009 Jun; 6(6):857-9. PubMed ID: 19467516
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial overview: from Vioxx to Luckenbach: drug discovery at a crossroads.
    Williams M
    Curr Opin Investig Drugs; 2005 Jan; 6(1):17-20. PubMed ID: 15675599
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to 'Heart failure at the crossroads: moving beyond blaming stakeholders to targeting the heart' [Eur J Heart Fail] 2015 August;17(8): 760-763. doi:10.1002/ejhf.315.
    Eur J Heart Fail; 2015 Dec; 17(12):1317. PubMed ID: 26647216
    [No Abstract]   [Full Text] [Related]  

  • 11. Heart failure at the crossroads: moving beyond blaming stakeholders to targeting the heart.
    Senni M; Gavazzi A; Gheorghiade M; Butler J
    Eur J Heart Fail; 2015 Aug; 17(8):760-3. PubMed ID: 26179815
    [No Abstract]   [Full Text] [Related]  

  • 12. Patents in Nanobiotechnology: A Cross Jurisdictional Approach.
    Manchikanti P; Uppala S; Bonta RK
    Recent Pat Biotechnol; 2017; 11(1):52-70. PubMed ID: 27881055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescent core-shell silica nanoparticles: towards "Lab on a Particle" architectures for nanobiotechnology.
    Burns A; Ow H; Wiesner U
    Chem Soc Rev; 2006 Nov; 35(11):1028-42. PubMed ID: 17057833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial: Biochips and nanobiotechnology.
    Park HG; Lee SY
    Biotechnol J; 2009 Nov; 4(11):1502-3. PubMed ID: 19918783
    [No Abstract]   [Full Text] [Related]  

  • 15. Taking a Concept to Commercialization: Designing Relevant Tests to Address Safety.
    Ferrara LA
    Spine (Phila Pa 1976); 2016 Apr; 41 Suppl 7():S8-9. PubMed ID: 27015077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial: Methods in nanobiotechnology.
    Gentile P; Tonda-Turo C
    Front Bioeng Biotechnol; 2022; 10():1067952. PubMed ID: 36406212
    [No Abstract]   [Full Text] [Related]  

  • 17. Biomarkers and proof of concept.
    Ferber G
    Methods Find Exp Clin Pharmacol; 2002; 24 Suppl C():35-40. PubMed ID: 12575486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic care at the crossroads: Exploring solutions for chronic care management. The "crossroads" and beyond.
    Nash DB
    Dis Manag; 2007; 10 Suppl 2():S1-2. PubMed ID: 18171138
    [No Abstract]   [Full Text] [Related]  

  • 19. Engineered cell culture substrates for axon guidance studies: moving beyond proof of concept.
    Roy J; Kennedy TE; Costantino S
    Lab Chip; 2013 Feb; 13(4):498-508. PubMed ID: 23288417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial overview: Signaling dynamics moving to the nanoscale.
    Moolenaar WH; Balla T
    Curr Opin Cell Biol; 2019 Apr; 57():iii-vi. PubMed ID: 30979378
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.